Please select the option that best describes you:

What gene mutations do you always test for prior to starting EGFR inhibitor therapy in metastatic colon cancer?  

Would you advocate for a targeted gene approach or a fully comprehensive NGS panel?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more